We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-12.35%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.3B
AUM Growth
-$444M
Cap. Flow
+$1.68B
Cap. Flow %
11.73%
Top 10 Hldgs %
21.62%
Holding
1,821
New
56
Increased
555
Reduced
957
Closed
250

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$101M
2
AMZN icon
Amazon
AMZN
+$99.5M
3
MSFT icon
Microsoft
MSFT
+$95.8M
4
LIN icon
Linde
LIN
+$84.2M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$40.4M

Sector Composition

Rank Sector Weight
1 Technology 19.27%
2 Healthcare 13.08%
3 Financials 12.21%
4 Consumer Discretionary 10.94%
5 Consumer Staples 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWN
976
DELISTED
Southwestern Energy Company
SWN
$467K ﹤0.01%
136,912
-12,590
-8% -$61.9K
NEU icon
977
NewMarket
NEU
$7.17B
$464K ﹤0.01%
1,127
-237
-17% -$93.8K
GDDY icon
978
GoDaddy
GDDY
$12.3B
$461K ﹤0.01%
7,031
-3,257
-32% -$223K
VVV icon
979
Valvoline
VVV
$4.97B
$461K ﹤0.01%
23,844
-5,266
-18% -$105K
RIG icon
980
Transocean
RIG
$5.92B
$460K ﹤0.01%
66,331
+8,295
+14% +$84.5K
VEEV icon
981
Veeva Systems
VEEV
$30.3B
$457K ﹤0.01%
5,122
-2,375
-32% -$217K
MTZ icon
982
MasTec
MTZ
$26.7B
$455K ﹤0.01%
11,218
+2,896
+35% +$125K
FNSR
983
DELISTED
Finisar Corp
FNSR
$454K ﹤0.01%
21,015
-3,912
-16% -$77.8K
TDOC icon
984
Teladoc Health
TDOC
$1.58B
$452K ﹤0.01%
9,110
-1,544
-14% -$94.5K
LOGM
985
DELISTED
LogMein, Inc.
LOGM
$452K ﹤0.01%
5,543
-1,964
-26% -$166K
RUBY
986
DELISTED
Rubius Therapeutics, Inc
RUBY
$451K ﹤0.01%
+28,076
New +$512K
BIO icon
987
Bio-Rad Laboratories Class A
BIO
$8.42B
$449K ﹤0.01%
1,933
-434
-18% -$116K
INSM icon
988
Insmed
INSM
$23.2B
$448K ﹤0.01%
34,153
-6,632
-16% -$106K
INGR icon
989
Ingredion
INGR
$6.38B
$447K ﹤0.01%
4,886
-1,209
-20% -$121K
INGN icon
990
Inogen
INGN
$167M
$444K ﹤0.01%
3,576
+358
+11% +$59K
VSM
991
DELISTED
Versum Materials, Inc.
VSM
$444K ﹤0.01%
16,012
-4,007
-20% -$127K
VMW
992
DELISTED
VMware, Inc
VMW
$439K ﹤0.01%
3,198
-1,396
-30% -$211K
CLVS
993
DELISTED
Clovis Oncology, Inc.
CLVS
$439K ﹤0.01%
24,435
-4,718
-16% -$96.4K
CMC icon
994
Commercial Metals
CMC
$7.63B
$437K ﹤0.01%
27,265
-4,940
-15% -$92.1K
SAVE
995
DELISTED
Spirit Airlines, Inc.
SAVE
$436K ﹤0.01%
7,535
-1,279
-15% -$68.5K
CTLT
996
DELISTED
CATALENT, INC.
CTLT
$435K ﹤0.01%
13,946
-3,164
-18% -$122K
SPPI
997
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$435K ﹤0.01%
49,700
-8,341
-14% -$106K
CHE icon
998
Chemed
CHE
$6.78B
$434K ﹤0.01%
1,532
-365
-19% -$110K
ARW icon
999
Arrow Electronics
ARW
$10.9B
$433K ﹤0.01%
6,274
-1,531
-20% -$109K
DK icon
1000
Delek US
DK
$3.87B
$433K ﹤0.01%
13,327
-779
-6% -$29.5K

Similar funds

ProShare Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, ProShare Advisors held 1,821 positions worth $14.3B, down 3% from $14.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

ProShare Advisors deployed $1.68B of net new capital in Q4 2018, opening 56 new positions and adding to 555 existing holdings. Its largest new stake was Linde: 532,831 shares worth $83.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was McCormick & Company Non-Voting, an estimated $14.7M trimmed.

  • ProShare Advisors's largest Q4 2018 buy was Linde: 532,831 shares worth $83.1M.
  • ProShare Advisors added most to Apple in Q4 2018, an estimated $101M increase.
  • ProShare Advisors's biggest Q4 2018 reduction was McCormick & Company Non-Voting, cutting an estimated $14.7M.
  • ProShare Advisors fully exited Praxair Inc in Q4 2018, selling an estimated $77.4M.
  • ProShare Advisors's ten largest holdings make up 22% of its $14.3B portfolio in Q4 2018.
  • ProShare Advisors opened 56 new positions and closed 250 in Q4 2018.
  • ProShare Advisors's portfolio value fell 3% quarter-over-quarter to $14.3B.

Based on ProShare Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.